Cargando…
Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: A RCT
BACKGROUND: Clomiphene citrate (CC) is the first line agent used for ovulation induction in patients with polycystic ovarian syndrome (PCOS). However, there is marked discrepancy between the ovulation and pregnancy rates achieved, which may be attributed to the undesirable effect of CC on cervical m...
Autores principales: | Mahran, Ahmad, Abdelmeged, Ayman, Shawki, Hossam, Moheyelden, Abdelrazek, Ahmed, Asmaa Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837925/ https://www.ncbi.nlm.nih.gov/pubmed/27141543 |
Ejemplares similares
-
Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome
por: Sakar, Mehmet Nafi, et al.
Publicado: (2020) -
Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment
por: Wang, LianLian, et al.
Publicado: (2017) -
Sildenafil citrate as an adjuvant to clomiphene citrate for ovulation induction in polycystic ovary syndrome: crossover randomized controlled trial
por: Mohammed, Walid E., et al.
Publicado: (2022) -
The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome
por: Akpinar, Funda, et al.
Publicado: (2016) -
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate
por: Nyboe Andersen, Anders, et al.
Publicado: (2008)